Investors showed caution ahead of Alphabet Inc.'s upcoming earnings release, with US equity futures slipping as markets weighed the impact of major tech companies' AI spending. The broader market remained sensitive, fueled by rising oil prices—Brent crude briefly surpassed $95 a barrel, its highest level in six weeks—after indications that nuclear negotiations between the US and Iran may not resume soon. This surge heightened inflation concerns and dampened risk sentiment, especially as a wave of corporate earnings reports looms. Market participants are closely watching whether Big Tech's strategic investments in artificial intelligence are translating into tangible financial results.
In a separate development, former President Donald Trump announced a new policy requiring generic drug manufacturers to relocate production to the United States by August 2028, or face a 100% import tariff. The directive aims to boost domestic pharmaceutical manufacturing but could threaten the availability and affordability of essential medications. Analysts warn the move might lead to supply chain disruptions and higher costs for consumers. Goldman Sachs strategist Christian Mueller-Glissmann discussed these dynamics on Bloomberg Brief, assessing how such policy shifts could influence investor sentiment and long-term market trends.